Indication

Primary hypogonadism due to bilateral torsion of testes

Primary hypogonadism due to bilateral torsion of testes is a form of hypergonadotropic hypogonadism in males characterized by acquired testicular failure following the twisting of both spermatic cords. Read more about Primary hypogonadism due to bilateral torsion of testes

106 drugs 67 manufacturers

Advertisement

Drugs that treat it

Common Primary hypogonadism due to bilateral torsion of testes therapies.

Showing 10–18 of 106 drugs

Filter & compare in the drug finder →Opens the drug finder with Primary hypogonadism due to bilateral torsion of testes preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Primary hypogonadism due to bilateral torsion of testes.

Primary hypogonadism due to bilateral torsion of testes is a form of hypergonadotropic hypogonadism in males characterized by acquired testicular failure following the twisting of both spermatic cords.

This vascular compromise causes severe ischemia and subsequent necrosis or atrophy of bilateral testicular parenchyma, profoundly damaging both Leydig cells and seminiferous tubules.

Pathophysiologically, the loss of functional testicular tissue results in deficient endogenous testosterone production and impaired spermatogenesis, triggering a compensatory elevation of pituitary gonadotropins, specifically luteinizing hormone and follicle-stimulating hormone, above the normal range.

Affected individuals typically present with clinical features of systemic androgen deficiency, including impaired sexual development or regression of secondary sex characteristics, reduced libido, fatigue, and infertility.

Personalize your experience

Follow Primary hypogonadism due to bilateral torsion of testes and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it